Variable | Result (n = 123) | |
---|---|---|
Age (years) | 51.9 years ±18.27 | |
Sex (count) | Male | 63 (51.2%) |
Female | 60 (48.8%) | |
Renal diagnosis (count) | ANCA-associated vasculitis | 50 (35.7%) |
Primary Glomerular disease | 33 (26.8%) | |
Lupus nephritis | 30 (24.4%) | |
Other | 10 (13.0%) | |
Renal function (eGFR by MDRDa equation) | 66 (39–90) | |
Duration of Prednisolone use (months) (data available for n = 63) | 18 (9–35) | |
Induction with intravenous methylprednisolone (count) (data available for n = 93) | 19 (20%) | |
Initial daily Prednisolone dose (mg) (data available for n = 79) | 50 (30–60) | |
Concurrent GC inhaler use (count) | 7 (5.7%) |